Carson PE - Search Results

1

Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.

Kao DP, Lewsey JD, Anand IS, Massie BM, Zile MR, Carson PE, McKelvie RS, Komajda M, McMurray JJ, Lindenfeld J. Kao DP, et al. Among authors: carson pe. Eur J Heart Fail. 2015 Sep;17(9):925-35. doi: 10.1002/ejhf.327. Epub 2015 Aug 6. Eur J Heart Fail. 2015. PMID: 26250359 Free PMC article. Clinical Trial.

2

Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT).

Carson P, Johnson G, Fletcher R, Cohn J. Carson P, et al. J Am Coll Cardiol. 1996 Mar 1;27(3):642-9. doi: 10.1016/0735-1097(95)00503-x. J Am Coll Cardiol. 1996. PMID: 8606276 Free article. Clinical Trial.

3

Pharmacologic treatment of congestive heart failure.

Carson P. Carson P. Clin Cardiol. 1996 Apr;19(4):271-7. doi: 10.1002/clc.4960190401. Clin Cardiol. 1996. PMID: 8706366 Free article. Review.

4

Beta blocker treatment in heart failure.

Carson PE. Carson PE. Prog Cardiovasc Dis. 1999 Jan-Feb;41(4):301-21. doi: 10.1053/pcad.1999.0410301. Prog Cardiovasc Dis. 1999. PMID: 10362350 Review.

5

Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.

Carson P, Ziesche S, Johnson G, Cohn JN. Carson P, et al. J Card Fail. 1999 Sep;5(3):178-87. doi: 10.1016/s1071-9164(99)90001-5. J Card Fail. 1999. PMID: 10496190 Clinical Trial.

6

Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure.

Carson PE. Carson PE. Am Heart J. 2000 Sep;140(3):361-6. doi: 10.1067/mhj.2000.109215. Am Heart J. 2000. PMID: 10966531 Review.

7

Beta-blocker therapy in heart failure.

Carson P. Carson P. Cardiol Clin. 2001 May;19(2):267-78, vi. doi: 10.1016/s0733-8651(05)70212-5. Cardiol Clin. 2001. PMID: 11407109 Review.

8

Effect of Valsartan on hospitalization: results from Val-HeFT.

Carson P, Tognoni G, Cohn JN. Carson P, et al. J Card Fail. 2003 Jun;9(3):164-71. doi: 10.1054/jcaf.2003.22. J Card Fail. 2003. PMID: 12815565 Clinical Trial.

9

Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT.

Krum H, Carson P, Farsang C, Maggioni AP, Glazer RD, Aknay N, Chiang YT, Cohn JN. Krum H, et al. Eur J Heart Fail. 2004 Dec;6(7):937-45. doi: 10.1016/j.ejheart.2004.09.005. Eur J Heart Fail. 2004. PMID: 15556056 Free article. Clinical Trial.

10

Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy.

O'Connor CM, Gottlieb S, Bourque JM, Krause-Steinrauf H, Anand I, Anderson JL, Plehn JF, Silver MA, White M, Carson P; BEST Investigators. O'Connor CM, et al. Am J Cardiol. 2005 Mar 1;95(5):558-64. doi: 10.1016/j.amjcard.2004.11.001. Am J Cardiol. 2005. PMID: 15721091 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters